SARS News and Research

RSS

Zoonotic spillover epidemics increasing at exponential rate, study finds

Four types of animal-to-human (zoonotic) Infections have been increasing at an "exponential rate," amid a general pattern of increasingly larger and more frequent 'spillover' epidemics, finds an analysis of 60 years of historical epidemiological data, published in the open access journal BMJ Global Health.

3 Nov 2023

A comprehensive database developed to help understand the basis of protein aggregation

Researchers at the IBB-UAB have developed the most comprehensive database available to date to help understand the basis of protein aggregation, a phenomenon associated with aging and several pathologies.

3 Nov 2023

Biomarker discovery boosts long-COVID prediction accuracy to 78.5%

Researchers identify four critical biomarkers associated with long-COVID, offering a 78.5% accuracy in predicting the condition. This discovery paves the way for diagnostic tests and offers insights into the mechanisms of persistent post-COVID symptoms.

1 Nov 2023

Masking up matters: High-quality studies confirm face masks significantly curb COVID-19 spread

This 'Special Communication' article in JAMA Network Open compiles high-quality studies to underline the effectiveness of face masks in curbing community-level transmission of SARS-CoV-2. The article emphasizes that surgical masks are more effective than cloth masks, and that mask-wearing is a vital public health tool, both in conjunction with and independent of other measures like vaccination and social distancing.

1 Nov 2023

Hospitalization and mortality risks from COVID-19 by age during SARS-CoV-2 Delta and Omicron variants’ predominance

Age-stratified hospitalization and mortality risks from incident SARS-CoV-2 infections.

1 Nov 2023

Influence of employment during COVID-19 on cognitive and motor functions among elders

The effects of employment on geriatric health during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak.

1 Nov 2023

From Cells to Drugs: How Cell Painting is Transforming Drug Discovery

In this interview, Jordi Carreras delves into the fascinating world of Cell Painting, a powerful technology gaining momentum in drug discovery. He shares insights into his groundbreaking research, the unique aspects of Phenaros' drug discovery platform, and the synergy between academia and industry.

From ELRIG (UK) Ltd. 1 Nov 2023

Next-generation vaccine candidates protect against multiple strains of influenza and last longer

Recent preclinical results indicate novel next-generation vaccine candidates developed at Cleveland Clinic protect against multiple strains of influenza and last longer than vaccines currently in use.

31 Oct 2023

How next-gen sequencing is changing antibody drug discovery

New study outlines how next-generation sequencing (NGS) and machine-learning methods can revolutionize antibody discovery, particularly against SARS-CoV-2. The research demonstrates that NGS provides greater epitopic and paratopic diversity, enabling more effective identification and prioritization of therapeutic antibodies.

31 Oct 2023

Study reveals how SARS-CoV-2 alters mitochondria, leading to energy outages and organ failure

The lungs were once at the forefront of SARS-Cov-2 research, but as reports of organ failure and other serious complications poured in, scientists set out to discover how and why the respiratory virus was causing serious damage to the body's major organs, including the lungs.

31 Oct 2023

Understanding COVID-19 mortality in people with severe mental illness and different ethnicities

In a recent study published in the British Journal of Psychiatry, researchers evaluated mortality in individuals with severe mental illness (SMI) following COVID-19.

31 Oct 2023

COVID-19’s long reach: Some physical symptoms can persist up to two years post-diagnosis

Researchers investigated the prevalence rate of physical-type symptoms by the severity of acute COVID-19 beyond two years of diagnosis.

31 Oct 2023

Human-to-lion COVID transmission confirmed: Singapore study rings alarm bells for endangered species

The study reveals that the SARS-CoV-2 delta variant was transmitted from humans to lions at a Singapore zoo, emphasizing the risk to captive and endangered animals. The researchers call for strict infection control measures and suggest vaccinations for susceptible animals to protect them from anthropogenic viral transmissions.

30 Oct 2023

New omicron sublineages surge, but Pfizer-BioNTech bivalent booster retains effectiveness

The efficacy of the bivalent Pfizer-BioNTech COVID-19 messenger ribonucleic acid (mRNA) vaccine BNT162b2 BA.4/5.

30 Oct 2023

Older adults still at highest risk of COVID-19 despite high vaccination rates

About 80% of residents in the Lower Mainland, British Columbia, had been infected with SARS-CoV-2 by July 2023 and were at low risk for severe outcomes, but almost half of the oldest adults remained uninfected and were at highest risk of hospitalization and death due to COVID-19, according to a new study published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.230721.

30 Oct 2023

Diabetic patients with COVID-19: low antibody levels linked to worse outcomes

The role of anti-SARS-CoV-2 antibody levels on COVID-19 outcomes in patients with T2D.

30 Oct 2023

SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a year

Researchers found that SARS-CoV-2 antigens can persist in the body for up to 14 months after initial infection, challenging the idea that COVID-19 is a transient illness. This finding has implications for understanding long-term effects of the virus and could influence future treatments and vaccines.

30 Oct 2023

SARS News and Research

Zoonotic spillover epidemics increasing at exponential rate, study finds

A comprehensive database developed to help understand the basis of protein aggregation

Biomarker discovery boosts long-COVID prediction accuracy to 78.5%

Masking up matters: High-quality studies confirm face masks significantly curb COVID-19 spread

Hospitalization and mortality risks from COVID-19 by age during SARS-CoV-2 Delta and Omicron variants’ predominance

Influence of employment during COVID-19 on cognitive and motor functions among elders

From Cells to Drugs: How Cell Painting is Transforming Drug Discovery

Next-generation vaccine candidates protect against multiple strains of influenza and last longer

How next-gen sequencing is changing antibody drug discovery

Study reveals how SARS-CoV-2 alters mitochondria, leading to energy outages and organ failure

Understanding COVID-19 mortality in people with severe mental illness and different ethnicities

COVID-19’s long reach: Some physical symptoms can persist up to two years post-diagnosis

Human-to-lion COVID transmission confirmed: Singapore study rings alarm bells for endangered species

New omicron sublineages surge, but Pfizer-BioNTech bivalent booster retains effectiveness

Older adults still at highest risk of COVID-19 despite high vaccination rates

Diabetic patients with COVID-19: low antibody levels linked to worse outcomes

SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a year

AI-nanopore platform can detect SARS-CoV-2 variants with high accuracy

Long COVID prevalence high in Scandinavians with severe COVID-19

From education to politics: a pan-European analysis of COVID-19 conspiracy theory influences

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News